JP2024514935A5 - - Google Patents
Info
- Publication number
- JP2024514935A5 JP2024514935A5 JP2023564409A JP2023564409A JP2024514935A5 JP 2024514935 A5 JP2024514935 A5 JP 2024514935A5 JP 2023564409 A JP2023564409 A JP 2023564409A JP 2023564409 A JP2023564409 A JP 2023564409A JP 2024514935 A5 JP2024514935 A5 JP 2024514935A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2021/060749 WO2021214329A1 (en) | 2020-04-24 | 2021-04-23 | Composition comprising an ige antibody |
| EPPCT/EP2021/060749 | 2021-04-23 | ||
| GBGB2109550.0A GB202109550D0 (en) | 2021-07-01 | 2021-07-01 | Composition |
| GB2109550.0 | 2021-07-01 | ||
| PCT/EP2022/060693 WO2022223784A1 (en) | 2021-04-23 | 2022-04-22 | Composition comprising an ige antibody |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024514935A JP2024514935A (ja) | 2024-04-03 |
| JP2024514935A5 true JP2024514935A5 (https=) | 2025-04-18 |
| JPWO2022223784A5 JPWO2022223784A5 (https=) | 2025-04-18 |
Family
ID=81750377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023564409A Pending JP2024514935A (ja) | 2021-04-23 | 2022-04-22 | ＩｇＥ抗体を含む組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240190955A1 (https=) |
| EP (1) | EP4326770A1 (https=) |
| JP (1) | JP2024514935A (https=) |
| KR (1) | KR20240001136A (https=) |
| AU (1) | AU2022263376A1 (https=) |
| BR (1) | BR112023021873A2 (https=) |
| CA (1) | CA3215850A1 (https=) |
| MX (1) | MX2023012557A (https=) |
| WO (1) | WO2022223784A1 (https=) |
| ZA (1) | ZA202309456B (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| ES2136092T3 (es) | 1991-09-23 | 1999-11-16 | Medical Res Council | Procedimientos para la produccion de anticuerpos humanizados. |
| CN103037900B (zh) | 2010-02-24 | 2016-04-06 | 伊缪诺金公司 | 叶酸受体1抗体与免疫缀合物以及其用途 |
| CA2848842C (en) | 2011-10-04 | 2020-09-29 | King's College London | Ige anti -hmw-maa antibody |
| RU2019141270A (ru) | 2017-05-16 | 2021-06-16 | Иммуноджен, Инк. | Комбинации анти-folr1 иммуноконъюгатов и анти-pd-1 антител |
| GB202006093D0 (en) * | 2020-04-24 | 2020-06-10 | King S College London | Composition |
-
2022
- 2022-04-22 AU AU2022263376A patent/AU2022263376A1/en active Pending
- 2022-04-22 EP EP22724722.8A patent/EP4326770A1/en active Pending
- 2022-04-22 KR KR1020237035816A patent/KR20240001136A/ko active Pending
- 2022-04-22 CA CA3215850A patent/CA3215850A1/en active Pending
- 2022-04-22 MX MX2023012557A patent/MX2023012557A/es unknown
- 2022-04-22 WO PCT/EP2022/060693 patent/WO2022223784A1/en not_active Ceased
- 2022-04-22 US US18/287,623 patent/US20240190955A1/en active Pending
- 2022-04-22 JP JP2023564409A patent/JP2024514935A/ja active Pending
- 2022-04-22 BR BR112023021873A patent/BR112023021873A2/pt unknown
-
2023
- 2023-10-10 ZA ZA2023/09456A patent/ZA202309456B/en unknown